Bristol-Myers Squibb | Kostnadene For Salg

Cost Of Sales Endring Dato
AbbVie USD 4.28B 90M 2023-12
ALKERMES USD 61.51M 1.75M 2023-09
Amgen USD 3.11B 1.31B 2023-12
AstraZeneca USD 2.06B 91M 2023-09
Catalent USD 853M 40M 2023-12
Eli Lilly USD 1.79B 72.1M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
GlaxoSmithKline GBP 2.24B 343M 2023-09
Perrigo USD 712.6M 52.5M 2023-09
Pfizer USD 6.66B 2.24B 2023-12
Prestige Brands USD 124.8M 1.49M 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06
United Therapeutics USD 71M 900K 2023-12
Zoetis USD 726M 89M 2023-12



Bristol-Myers Squibb Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.